Lung Cancer Treatment History timeline
-
Fritz Lickint Finds Evidence that Links Lung Cancer and Cigarettes
It is interesting to note, however, that in 1929 (presumably too late to be included in the handbook) the German physician, Fritz Lickint published... Read more
-
FDA Approves Bristol Myers Squibb's VePesid
Treating patients with lung cancer and recurrent testicular tumors. It is used in combination with other cancer medications. VePesid is an... Read more
-
Lung Cancer Becomes Leading Cause of Cancer Death in Women
Lung cancer has been the leading cause of cancer death among women since 1987, claiming the lives of 70,490 women in 2009. Read more
-
FDA Approves Bristol Myers Squibb's Taxol
Taxol is one of the newer chemotherapy drugs, and has been around, and in use for some years. It is an extract from the bark and needles of the yew... Read more
-
FDA Approves Pierre Fabre's Navelbine
NAVELBINE is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable,... Read more
-
FDA Approves Teva's Toposar
Treating lung cancer and testicular tumors in patients who have not responded to other treatment. It is used in combination with other cancer... Read more
-
FDA Approves Sanofi Aventis's Taxotere
Drug Type: Taxotere is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Taxotere is classified as a "plant alkaloid," a... Read more
-
FDA Approves Lilly's Gemzar
Gemzar is indicated in combination with cisplatin for the first-line treatment of patients with inoperable, locally advanced (Stage IIIA or IIIB)... Read more
-
FDA Approves Bristol Myers Squibb's Etopophos
Treating lung cancer and testicular tumors in patients who have not responded to other treatment. It is used in combination with other cancer... Read more
-
FDA Approves BARR's Trexall
Treating certain types of cancer, severe psoriasis, or rheumatoid arthritis in certain patients. It may be used alone or with other medicines. It... Read more
-
FDA Approves AstraZeneca's Iressa
IRESSA is indicated as monotherapy for the continued treatment of patients with locally advanced or metastatic non-small cell lung cancer after... Read more
-
FDA Approves Lilly's Alimta
Alimta® is the very first chemotherapy drug to be approved by the Food and Drug Administration (FDA) to treat patients suffering from malignant... Read more
-
FDA Approves Genentech's Avastin
Avastin is a cancer medicine that interferes with the growth of cancer cells by blocking the formation and growth of new blood vessels in the tumor... Read more
-
FDA Approves OSI Pharms' Tarceva
Non-Small Cell Lung Cancer (NSCLC) TARCEVA monotherapy is indicated for the maintenance treatment of patients with locally advanced or... Read more
-
FDA Approves GlaxoSmithKline's Hycamtin Capsules for Patients with Lung Cancer
Hycamtin (topotecan) is a semi-synthetic derivative of camptothecin and is an anti-tumor drug with topoisomerase I-inhibitory activity.... Read more
-
Blood Pressure Drugs Linked to Increased Risk of Cancer
A blood pressure drug used by millions of adults could be increasing their risk of cancer, a study has revealed. The use of ARB drugs to treat... Read more